|
Last Updated: Nov 18, 2006 - 12:32:53 PM |
Latest Research
:
Public Health
:
Immunization
:
Vaccination
New Non-Invasive Vaccine Strategy May Offer Protection Against Tetanus and Anthrax
A new vaccine strategy using genetically engineered bacteria topically applied to the skin elicits an immune response to both tetanus and anthrax in animals say researchers from Vaxin Inc., Birmingham, Alabama. They report their findings in the June 2006 issue of the journal Infection and Immunity.
Jun 15, 2006 - 6:03:00 PM
Latest Research
:
Public Health
:
Immunization
:
Vaccination
Vaccine developed against dust mite allergy
A Swiss company has developed a vaccine that it claims could be effective against dust mite allergy. Cytos, one of a number of firms developing anti-allergen vaccines, carried out a study of the new vaccine and found significant benefits against dust mite allergy.
Apr 27, 2006 - 1:42:00 PM
Latest Research
:
Public Health
:
Immunization
:
Vaccination
Rotavirus vaccine will protect children against a major killer worldwide
The Food and Drug Administration (FDA) today announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year. The vaccine, developed by Merck & Co., Inc., will be sold as ROTATEQ� and will protect infants against rotavirus infection. Rotavirus is a highly contagious virus that is the most common cause of severe dehydrating diarrhea in infants and young children.
Feb 5, 2006 - 12:45:00 AM
Latest Research
:
Public Health
:
Immunization
:
Vaccination
World's First Plant-made Vaccine Registered
Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, announced today that it has received the world's first regulatory approval for a plant-made vaccine from the United States Department of Agriculture (USDA) Center for Veterinary Biologics. This approval represents an innovative milestone for the company and the industry.
Jan 31, 2006 - 9:58:00 PM
Latest Research
:
Public Health
:
Immunization
:
Vaccination
A solution to increase the efficacy of vaccines
Researchers have demonstrated a technique that has the potential to reduce the toxicity of vaccines and to make smaller doses more effective, according to a study published in PLoS Pathogens. Developing vaccines is fraught with challenges, particularly because many candidates carry a high risk of toxic side effects. For example, twenty percent of people immunized against smallpox will suffer side effects. Wilfred Jefferies, a researcher at the University of British Columbia and senior author of the study, and his colleagues have shown that boosting the production of TAP, an immune system component, can make smaller doses of vaccines more effective.
Dec 30, 2005 - 3:45:00 PM
Latest Research
:
Public Health
:
Immunization
:
Vaccination
Large Study Finds No Link Between Multiple Childhood Vaccinations And Subsequent Hospitalization For Nontargeted Diseases
New research does not support a belief that children receiving multiple vaccines increase their risk of hospitalization for a nontargeted infectious disease, according to a study in the August 10 issue of JAMA.
Aug 10, 2005 - 11:15:00 PM
<< prev
next >>
|
